While the studies of breast cancer and colorectal carcinoma cells support a role of Abi1 in breast cancer and colorectal cancer development in vitro and in vivo [35–37], other studies suggest that Abi1 may function as a tumor suppressor in prostate cancer and gastric carcinoma development [38–40]. Here, ABI1 is linked to gastric carcinoma.